WeVote

Bill

Bill

SB 225

Public health; establishing the Oklahoma Rare Disease Advisory Council. Effective date.

2025 Regular Session Introduced by Carri Hicks

Oklahoma establishes a Rare Disease Advisory Council to coordinate patient care, research, and policy for rare disease management across the state.

Second Reading referred to Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 225

Legislative bill overview

SB 225 establishes the Oklahoma Rare Disease Advisory Council, a new state advisory body focused on rare disease policy and patient advocacy. The bill creates a formal structure for coordinating rare disease efforts across Oklahoma's healthcare and public health systems.

Why is this important

Rare diseases affect millions of Americans but often receive limited research funding and medical attention due to their small patient populations. By creating a dedicated advisory council, Oklahoma aims to improve coordination, awareness, and resource allocation for patients with rare conditions, potentially improving diagnosis times and treatment access.

Potential points of contention

  • Funding and staffing: No details provided on budget allocation, operational costs, or whether council members are compensated, which could affect implementation feasibility
  • Council composition and authority: Unclear whether the council will have advisory-only power or actual decision-making authority, and who will be appointed to represent various stakeholder groups
  • Scope and deliverables: The bill's specific objectives and measurable outcomes for the council are not detailed, raising questions about accountability and effectiveness metrics

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.